Clinical Trial Update: Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

A Phase 3 study comparing Test to Aczone 7.5% and to placebo in acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Aczone 7.5% (dapsone)
• Test

Snippet

Sponsor: Torrent Pharmaceuticals Limited | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED